Product Information
TACROLIMUS 0.03% OINTMENT is a generic product labeled by Padagis Israel Pharmaceuticals Ltd, priced at $0.9036 per GM under NDC 45802039001. Its NADAC has been published 601 times since Feb 18, 2015.
FDA first approved this application on Dec 8, 2000. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
.3 mg/g
Manufacturer
Padagis Israel Pharmaceuticals LtdNDC
45802039001
Classification
Generic
Dosage Form
OINTMENT
Route
TOPICAL
Effective Date
8/19/2026
Active Ingredients
TACROLIMUSApproval Type
New Drug (NDA)
FDA Application
NDA050777FDA Approved
12/8/2000
TE Code
AB
On Market Since
11/20/2014
Pharmacological Classes
Price Statistics
The NADAC for TACROLIMUS 0.03% OINTMENT has been published 601 times since Feb 18, 2015, and over the history we have for it it has declined 85.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.9036 per GM |
|---|---|
| All-time high | $6.5168 (Jun 10, 2015) |
| All-time low | $0.5582 (May 22, 2024) |
| 52-week high | $0.9246 |
| 52-week low | $0.7651 |
| Median price | $3.3858 |
| Average price | $3.2451 |
| Largest weekly change | +50.4% (Mar 22, 2023) |
| Weeks tracked | 601 |
| Tracking since | Feb 18, 2015 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 34% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of TACROLIMUS 0.03% OINTMENT?
The current National Average Drug Acquisition Cost (NADAC) for TACROLIMUS 0.03% OINTMENT, manufactured by Padagis Israel Pharmaceuticals Ltd, is $0.9036 per GM (NDC 45802039001), effective Aug 19, 2026.
How has the price of TACROLIMUS 0.03% OINTMENT changed over time?
Over the history we have for it, the NADAC for TACROLIMUS 0.03% OINTMENT has declined 85.7%. It has been tracked across 601 weekly CMS publications since Feb 18, 2015.
What are the highest and lowest recorded NADAC prices for TACROLIMUS 0.03% OINTMENT?
Since Feb 18, 2015, the NADAC for TACROLIMUS 0.03% OINTMENT has ranged from a low of $0.5582 (May 22, 2024) to a high of $6.5168 (Jun 10, 2015), with a median of $3.3858 per GM.
Are there cheaper alternatives to TACROLIMUS 0.03% OINTMENT?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, TACROLIMUS 0.03% OINTMENT, is $0.5924 per GM — about 34% below TACROLIMUS 0.03% OINTMENT.
Who manufactures TACROLIMUS 0.03% OINTMENT?
TACROLIMUS 0.03% OINTMENT (NDC 45802039001) is labeled by Padagis Israel Pharmaceuticals Ltd, and CMS classifies it as a generic product.